Evaluation and treatment of community-acquired Staphylococcus aureus infections in term and late-preterm previously healthy neonates

Pediatrics

Volumn 120, Issue 5, 2007, Pages 937-945

  Fortunov, Regine M ^a,b   Hulten, Kristina G ^a,b   Hammerman, Wendy A ^a,b   Mason Jr , Edward O ^a,b   Kaplan, Sheldon L ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

Community acquired Staphylococcus aureus; Infant; Methicillin resistance; Newborn; Therapy

Indexed keywords

ACICLOVIR; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; BACITRACIN; CEFALEXIN; CEFTRIAXONE; CEPHALOSPORIN; CLINDAMYCIN; ERYTHROMYCIN; EYE OINTMENT; GENTAMICIN; NAFCILLIN; NEOSPORIN; PSEUDOMONIC ACID; VANCOMYCIN;

ABSCESS; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIUM ISOLATE; BLOOD CULTURE; CELLULITIS; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID CULTURE; CLINICAL EVALUATION; CLINICAL FEATURE; COMMUNITY ACQUIRED INFECTION; EVALUATION; FEMALE; HERPES SIMPLEX; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HOSPITAL READMISSION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MASTITIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NEWBORN; NEWBORN INFECTION; OUTPATIENT CARE; PLEOCYTOSIS; PREMATURITY; PRIORITY JOURNAL; PUSTULOSIS; REINFECTION; RETROSPECTIVE STUDY; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; TREATMENT DURATION; TREATMENT OUTCOME; UNITED STATES; URINARY TRACT INFECTION; URINE CULTURE;

ANTI-BACTERIAL AGENTS; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; MALE; METHICILLIN RESISTANCE; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 36048982750     PISSN: 00314005     EISSN: 02105721     Source Type: Journal    
DOI: 10.1542/peds.2007-0956     Document Type: Article

References (26)

1. Orscheln RC, Shinefield HR, St Geme JW 3rd. Staphylococcal infections. In: Remington JS, Klein JO, Wilson CB, Baker CJ, eds. Infectious Diseases of the Fetus and Newborn Infant. 6th ed. Philadelphia, PA: Elsevier Saunders; 2006:512-543
2. Healy CM, Hulten KG, Palazzi DL, Campbell JR, Baker CJ. Emergence of new strains of methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit. Clin Infect Dis. 2004;39:1460-1466
3. Fortunov RM, Hulten KG, Hammerman WA, Mason EO Jr, Kaplan SL. Community-acquired Staphylococcus aureus infections in term and near-term previously healthy neonates. Pediatrics. 2006;118:874-881
4. Laibl VR, Sheffield JS, Roberts S, McIntire DD, Trevino S, Wendel GD Jr. Clinical presentation of community-acquired methicillin-resistant Staphylococcus aureus in pregnancy. Obstet Gynecol. 2005;106:461-465
5. Reddy P, Qi C, Zembower T, Noskin GA, Bolon M. Postpartum mastitis and community-acquired methicillin-resistant Staphylococcus aureus. Emerg Infect Dis. 2007;13:298-301
6. Dehority W, Wang E, Vernon PS, Lee C, Perdreau-Remington F, Bradley J. Community-associated methicillin-resistant Staphylococcus aureus necrotizing fasciitis in a neonate. Pediatr Infect Dis J. 2006;25:1080-1081
7. Centers for Disease Control and Prevention. Community-associated methicillin-resistant Staphylococcus aureus infection among healthy newborns: Chicago and Los Angeles County, 2004. MMWR Morb Mortal Wkly Rep. 2006;55:329-332
8. Bradley J, Frenck R. CA-MRSA infections an increasing concern in early infancy. AAP News. 2006;27:16
9. Mishaan AM, Mason EO Jr, Martinez-Aguilar G, et al. Emergence of a predominant clone of community-acquired Staphylococcus aureus among children in Houston, Texas. Pediatr Infect Dis J. 2005;24:201-206
10. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Disk Susceptibility Testing: 17th Informational Supplement. Wayne, PA: Clinical and Laboratory Standards Institute; 2007
11. Sarff LD, Platt LH, McCracken GH Jr. Cerebrospinal fluid evaluation in neonates: comparison of high-risk infants with and without meningitis. J Pediatr. 1976;88:473-477
12. Murray BE, Singh KV, Heath JD, Sharma BR, Weinstock GM. Comparison of genomic DNAs of different enterococcal isolates using restriction endonucleases with infrequent recognition sites. J Clin Microbiol. 1990;28:2059-2063
13. Hulten KG, Kaplan SL, Gonzalez BE, et al. Three-year surveillance of community onset health care-associated Staphylococcus aureus infections in children. Pediatr Infect Dis J. 2006;25:349-353
14. Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol. 1995;33:2233-2239
15. Manroe BL, Rosenfeld CR, Weinberg AG, Browne R. The differential leukocyte count in the assessment and outcome of early-onset neonatal group B streptococcal disease. J Pediatr. 1977;91:632-637
16. Syrogiannopoulos GA, Grivea IN, Anastassiou ED, Triga MG, Dimitracopoulos GO, Beratis NG. Sterile cerebrospinal fluid pleocytosis in young infants with urinary tract infection. Pediatr Infect Dis J. 2001;20:927-930
17. Ginsburg CM, McCracken GH Jr. Urinary tract infections in young infants. Pediatrics. 1982;69:409-412
18. American Academy of Pediatrics. Staphylococcal infections. In: Pickering LK, Baker CJ, Long SS, McMillan JA, eds. Red Book: 2006 Report of the Committee on Infectious Diseases. 27th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2006:598-610
19. Autret E, Laugier J, Marimbu J, Vaillant MC, Furet Y, Breteau M. Comparison of plasma levels of amoxicillin administered by oral and intravenous routes in neonatal bacterial colonization [in French]. Arch Fr Pediatr. 1988;45:679-682
20. Boothman R, Kerr MM, Marshall MJ, Burland WL. Absorption and excretion of cephalexin by the newborn infant. Arch Dis Child. 1973;48:147-150
21. Lwin N, Collipp PJ. Absorption and tolerance of clindamycin-2-palmitate in infants below 6 months of age. Curr Ther Res Clin Exp. 1970;12:648-657
22. American Academy of Pediatrics. Table 4.2: Antibacterial drugs for newborn infants: dose (mg/kg or U/kg) and frequency of administration. In: Pickering LK, Baker CJ, Long SS, McMillan JA, eds. Red Book: 2006 Report of the Committee on Infectious Diseases. 27th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2006:751-752
23. Andersen DH, Blanc WA, Crozier DN, Silverman WA. A difference in mortality rate and incidence of kernicterus among premature infants allotted to two prophylactic antibacterial regimens. Pediatrics. 1956;18:614-625
24. Johnson L, Sarmiento F, Blanc WA, Day R. Kernicterus in rats with an inherited deficiency of glucuronyl transferase. AMA J Dis Child. 1959;97:591-608
25. Odell GB. Studies in kernicterus: I. The protein binding of bilirubin. J Clin Invest. 1959;38:823-833
26. Zyvox. In: Sanborn KD, eds. Physicians' Desk Reference. 61st ed. Montvale, NJ: Thomson PDR; 2007:2652-2660